Literature DB >> 17716352

Prevalence and etiology of elevated serum alanine aminotransferase level in an adult population in Taiwan.

Chien-Hua Chen1, Min-Ho Huang, Jee-Chun Yang, Chiu-Kue Nien, Chi-Chieh Yang, Yung-Hsiang Yeh, Sen-Kou Yueh.   

Abstract

BACKGROUND: The prevalence and etiologies of elevated alanine aminotransferase (ALT) have geographic variations and they are rarely reported in Taiwan. Through a population-based screening study, the prevalence and etiologies of elevated ALT in an adult population of Taiwan were assessed.
METHODS: A cross-sectional community study in a rural village of Taiwan was conducted in 3260 Chinese adults (age >or=18 years) undergoing ultrasonography (US), blood tests, and interviews with a structured questionnaire. The diagnostic criteria of non-alcoholic fatty liver disease (NAFLD) included alcohol intake <20 g/week for women or <30 g/week for men, negative hepatitis B virus (HBV) and hepatitis C virus (HCV) infections, no known etiologies of liver disease, and US consistent with fatty liver.
RESULTS: The prevalence of elevated ALT was 11.4% (372/3260). The probable cause of this elevation was excess alcohol consumption in 0.8%, HBV in 28.5%, HCV in 13.2%, both HBV and HCV in 2.2%, NAFLD in 33.6%, and unexplained cause in 21.8%. The etiologic distribution of elevated ALT was similar in both genders, although elevation was more common in men compared to women (17.3%vs 6.1%, P < 0.05). The prevalence of elevated ALT in NAFLD was 18.1% (125/691), and the positive predictive value was 33.6% (125/372). The development of NAFLD was related to increasing age (age between 40 years and 64 years, odds ratio [OR] 1.59, 95% confidence interval [CI]: 1.25-2.01; age >or= 65 years, OR 1.46, 95%CI: 1.08-1.96), fasting plasma glucose (FPG) >or= 126 mg/dL (OR 1.54, 95%CI: 1.11-2.14), body mass index (BMI) >or= 25 kg/m(2) (OR 5.01, 95%CI: 4.13-6.26), triglyceridemia >or= 150 mg/dL (OR 1.96, 95%CI: 1.58-2.42), and hyperuricemia (OR 1.50, 95%CI: 1.22-1.84). Elevated ALT was related to male gender, BMI >or= 25 kg/m(2), and triglyceridemia >or= 150 mg/dL in subjects without known etiologies of liver disease (all P < 0.05).
CONCLUSIONS: Non-alcoholic fatty liver disease appears to be the commonest cause of elevated ALT and presumed liver injury in Taiwan. The development of NAFLD is closely associated with many metabolic disorders. Metabolic disorders are also related to elevated ALT in subjects without known etiologies of liver disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17716352     DOI: 10.1111/j.1440-1746.2006.04615.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  47 in total

1.  After successful hepatitis C virus antiviral therapy: It looks that normal alanine aminotransferase level is not the normal.

Authors:  Mohamed El Kassas; Mohamed Alboraie; Aya Mostafa; Reem Ezzat; Adel El Tahan; Shimaa Afify; Ahmed Sweedy; Ibrahim Kabbash; Gamal Esmat
Journal:  J Clin Lab Anal       Date:  2017-07-28       Impact factor: 2.352

2.  Epidemiology and Natural History of Non-alcoholic Fatty Liver Disease.

Authors:  Alita Mishra; Zobair M Younossi
Journal:  J Clin Exp Hepatol       Date:  2012-07-21

3.  Determination of the upper cut-off values of serum alanine aminotransferase and aspartate aminotransferase in Chinese.

Authors:  Peng Zhang; Chun-Yan Wang; Yu-Xiang Li; Yu Pan; Jun-Qi Niu; Shu-Mei He
Journal:  World J Gastroenterol       Date:  2015-02-28       Impact factor: 5.742

Review 4.  Obesity and non-alcoholic fatty liver disease: Disparate associations among Asian populations.

Authors:  Robert J Wong; Aijaz Ahmed
Journal:  World J Hepatol       Date:  2014-05-27

5.  Biochemical Profile of Nonalcoholic Fatty Liver Disease Patients in Eastern India with Histopathological Correlation.

Authors:  Manorama Swain; Preetam Nath; Prasant Kumar Parida; Jimmy Narayan; Pradeep Kumar Padhi; Girish Kumar Pati; Ayaskanta Singh; Bijay Misra; Debasis Misra; Sanjib Kumar Kar; Manas Kumar Panigrahi; Chudamani Meher; Omprakash Agrawal; Niranjan Rout; Kaumudee Pattnaik; Pallavi Bhuyan; Pramila Kumari Mishra; Shivaram Prasad Singh
Journal:  Indian J Clin Biochem       Date:  2016-09-03

Review 6.  NAFLD in Asia--as common and important as in the West.

Authors:  Geoffrey C Farrell; Vincent Wai-Sun Wong; Shiv Chitturi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-03-05       Impact factor: 46.802

7.  Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest).

Authors:  Thierry Poynard; Pascal Lebray; Patrick Ingiliz; Anne Varaut; Brigitte Varsat; Yen Ngo; Pascal Norha; Mona Munteanu; Fabienne Drane; Djamila Messous; Françoise Imbert Bismut; Jean Pierre Carrau; Julien Massard; Vlad Ratziu; Jean Pierre Giordanella
Journal:  BMC Gastroenterol       Date:  2010-04-22       Impact factor: 3.067

8.  Non-alcoholic Fatty Liver Disease: East Versus West.

Authors:  Swastik Agrawal; Ajay K Duseja
Journal:  J Clin Exp Hepatol       Date:  2012-07-21

9.  Alanine aminotransferase isoenzymes: molecular cloning and quantitative analysis of tissue expression in rats and serum elevation in liver toxicity.

Authors:  Rong-Ze Yang; Soohyun Park; William J Reagan; Rick Goldstein; Shao Zhong; Michael Lawton; Francis Rajamohan; Kun Qian; Li Liu; Da-Wei Gong
Journal:  Hepatology       Date:  2009-02       Impact factor: 17.425

10.  Clinical and histological determinants of nonalcoholic steatohepatitis and advanced fibrosis in elderly patients.

Authors:  Mazen Noureddin; Katherine P Yates; Ivana A Vaughn; Brent A Neuschwander-Tetri; Arun J Sanyal; Arthur McCullough; Raphael Merriman; Bilal Hameed; Edward Doo; David E Kleiner; Cynthia Behling; Rohit Loomba
Journal:  Hepatology       Date:  2013-10-02       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.